Dissemination of high-level mupirocin-resistant CC22-MRSA-IV in Saxony

2017/11/20 by Stefan Monecke, Antje Ruppelt-Lorz, Monecke, Stefan +15
Biochemistry, Genetics and Molecular Biology · Medicine · #610 Medical sciences #Antibiotic Resistance in Bacteria #Antimicrobial Resistance in Staphylococcus #MRSA #Medicine #Methicillin-resistente Staphylococcus aureus #Mupirocin #Pneumonia and Respiratory Infections #high-level mupirocin resistance #hochgradige Mupirocin-Resistenz #methicillin-resistant Staphylococcus aureus #mupA #mupirocin #“Barnim Epidemic Strain” #„Barnimer Epidemiestamm“

paper · doi:10.3205/dgkh000304

openalex publication_date 2017/11/20 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/22

Abstract

(C). In order to prevent therapy failures and a further spread of this strain, the use of mupirocin should be more stringently controlled as well as guided by susceptibility testing. In addition, MRSA decolonization regimens that rely on other substances, such as betaisodona, polyhexanide or octenidine, should be considered.

Related

• Outbreak of Methicillin‐resistant Staphylococcus aureus in a Hospital Center for Children's and Women's Health in a Swedish County
• Highly Effective Regimen for Decolonization of Methicillin-ResistantStaphylococcus aureusCarriers
• Adherence to national recommendations for the control of multidrug-resistant microorganisms in Swiss acute care hospitals - an updated national survey
• Evaluation of the Impact of Universal Mupirocin Decolonization in Intensive Care Units on the Utility of Methicillin-Resistant Staphylococcus aureus PCR Nasal Swab Testing
• Management of patients with multidrug-resistant organisms in rehabilitation facilities. Results of a survey in the Rhine-Main region, Germany, 2019